Title | Interleukin-1 mediates long-term hippocampal dentate granule cell loss following postnatal viral infection. |
Publication Type | Journal Article |
Year of Publication | 2010 |
Authors | Orr AG, Sharma A, Binder NB, Miller AH, Pearce BD |
Journal | J Mol Neurosci |
Volume | 41 |
Issue | 1 |
Pagination | 89-96 |
Date Published | 2010 May |
ISSN | 1559-1166 |
Keywords | Animals, Animals, Newborn, Dentate Gyrus, Humans, Interleukin 1 Receptor Antagonist Protein, Interleukin-1beta, Lymphocytic Choriomeningitis, Rats, Rats, Inbred Lew |
Abstract | Viral infections of the developing CNS can cause long-term neuropathological sequela through undefined mechanisms. Proinflammatory cytokines such as IL-1beta have gained attention in mediating neurodegeneration in corticohippocampal structures due to a variety of insults in adults, though there is less information on the developing brain. Little is known concerning the spatial-temporal pattern of IL-1beta induction in the developing hippocampus following live virus infection, and there are few studies addressing the long-term consequences of this cytokine induction. We report that infection of rats with lymphocytic choriomeningitis virus on postnatal day 4 induces IL-1beta protein in select regions of the hippocampus on 6, 15, 21, and 45 days after infection. This infection resulted in a 71% reduction of dentate granule cell neurons by the time the rats reached mid-adulthood. We further investigated the causative role of IL-1 in this dentate granule cell loss by blocking IL-1 activity using an IL-1ra-expressing adenoviral vector administered at the time of infection. Blockade of IL-1 abrogated the infection-associated neuron loss in this vivo model. Considering that IL-1 can be triggered by multiple perinatal insults, our findings suggest that early therapy with anti-inflammatory agents that block IL-1 may be effective for reducing adulthood neuropathology. |
DOI | 10.1007/s12031-009-9293-5 |
Alternate Journal | J. Mol. Neurosci. |
PubMed ID | 19774496 |
Grant List | 5R29NS037068 / NS / NINDS NIH HHS / United States |